Free Trial
OTCMKTS:SARTF

Sartorius (SARTF) Stock Price, News & Analysis

Sartorius logo
$208.82 0.00 (0.00%)
As of 07/11/2025

About Sartorius Stock (OTCMKTS:SARTF)

Key Stats

Today's Range
$208.82
$208.82
50-Day Range
$187.82
$210.47
52-Week Range
$165.00
$243.35
Volume
N/A
Average Volume
4 shs
Market Capitalization
N/A
P/E Ratio
141.09
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Receive SARTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius and its competitors with MarketBeat's FREE daily newsletter.

SARTF Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Sartorius lifts U.S. peers after 2024 results
Sartorius 9-month Underlying Net Profit Declines; Confirms 2024 Guidance
Sartorius vz earnings: here's what Wall Street expects
See More Headlines

SARTF Stock Analysis - Frequently Asked Questions

Sartorius' stock was trading at $184.00 at the beginning of 2025. Since then, SARTF stock has increased by 13.5% and is now trading at $208.8150.

Sartorius (OTCMKTS:SARTF) released its earnings results on Wednesday, April, 16th. The company reported $1.28 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.28. The business earned $959.23 million during the quarter, compared to the consensus estimate of $867.08 million. Sartorius had a net margin of 2.76% and a trailing twelve-month return on equity of 7.62%.

The following companies are subsidiaries of Sartorius: Novasep’s chromatography division, ALS Automated Lab Solutions GmbH, Xell AG, CellGenix Inc., WaterSep BioSeparations LLC, BIA Separations, Biological Industries, and more.

Shares of SARTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
4/16/2025
Today
7/15/2025
Next Earnings (Estimated)
7/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
N/A
Current Symbol
OTCMKTS:SARTF
Previous Symbol
NASDAQ:SARTF
CIK
N/A
Employees
13,528
Year Founded
1870

Profitability

EPS (Trailing Twelve Months)
$1.48
Trailing P/E Ratio
141.09
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$90.90 million
Net Margins
2.76%
Pretax Margin
6.16%
Return on Equity
7.62%
Return on Assets
2.92%

Debt

Debt-to-Equity Ratio
1.09
Current Ratio
1.46
Quick Ratio
0.93

Sales & Book Value

Annual Sales
$3.66 billion
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.07

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:SARTF) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners